Compounds > 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin
Page last updated: 2024-10-21

2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin and Drug Withdrawal Symptoms

2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin has been researched along with Drug Withdrawal Symptoms in 1 studies

2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin: potent, specific D2 dopamine receptor agonist; RN given refers to parent cpd

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Samochowiec, J1
Kleinrok, Z1
Jagiełło-Wójtowicz, E1
Horodnicki, J1
Rommelspacher, H1
Schmidt, LG1

Other Studies

1 other study available for 2-(n-phenethyl-n-propyl)amino-5-hydroxytetralin and Drug Withdrawal Symptoms

ArticleYear
Effects of dopaminergic agonists and antagonists on the serum prolactin levels in alcoholized rats.
    Polish journal of pharmacology, 1997, Volume: 49, Issue:4

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Central Nervous S

1997